超病毒性Klebsiella肺炎:流行病学,检测和抗生素耐药性的最新情况
1Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary.
Acta microbiologica et immunologica Hungarica
|December 4, 2023
概括
高病毒性Klebsiella肺炎 (hvKP) 导致严重的社区感染. 在hvKP中出现的抗生素耐药性,包括carbapenemases,构成了重大的全球健康挑战.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 遗传学 遗传学 是一个
背景情况:
- 肺炎Klebsiella是一种重要的人类病原体.
- 在全球范围内出现了高病毒性K. pneumoniae (hvKP) 菌株.
- 在健康人群中,hvKP会引起严重的感染,通常涉及多个部位.
研究的目的:
- 审查高病毒性K. pneumoniae的流行病学,检测和抗生素耐药性.
- 总结定义hvKP病型的遗传和表型特征.
- 突出抗生素耐药性hvKP.所带来的不断变化的挑战.
主要方法:
- 文献综述总结了关于hvKP的当前知识.
- 对遗传标记 (magA,rmpA,iucABCD) 和囊血清型 (K1,K2等) 的分析. 与过度病毒发作相关.
- 检查等离子体介导的毒性因子和水平基因转移.
主要成果:
- hvKP的特点是病毒性因素的组合,包括粘性和特定的血清型/基因.
- 常见的临床表现包括发热性肝,脑膜炎和肺炎.
- 产生卡巴酶的hvKP (如KPC,VIM,NDM,OXA-48) 和高危克隆 (ST11,ST147,ST307) 的出现越来越令人担忧.
结论:
- 由于其毒性和抗生素耐药性的增加,hvKP 构成了极大的威胁.
- 了解hvKP的流行病学和耐药性机制对于有效控制至关重要.
- 在K. pneumoniae中,高病毒性和碳烯耐药性的组合对公共卫生构成了令人震惊的挑战.
更多相关视频
06:11Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
1.8K
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.7K
相关概念视频
01:30Pneumonia III: Complications and Assessment
239
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
239
01:28Pneumonia IV: Management
333
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
333